MYD88 and B-cell chronic lymphocytic leukemia: The authors also emphasize that cases of CLL patients with TLR/MYD88 mutations showed overexpression of genes related to the nuclear factor κB pathway and that patients with TLR/MYD88 mutations were significantly younger, 83% of them were ≤50 years of age, compared to patients without the mutation.